EpiPen Maker Mylan Will Pay $465 Million to Settle Medicaid Overcharging Case
Mylan said the settlement, after the government had said it improperly classified EpiPen as a generic drug, did not imply any admission of wrongdoing. [Source]
Publication Date:Origin: nytimes.com
Category: Medical Devices
Topics: Mylan, EpiPen, wrongdoing, admission, imply, generic, classified, improperly, government, settlement, Overcharging, Medicaid, Settle, Million, Maker